4.17
price down icon2.57%   -0.11
after-market Dopo l'orario di chiusura: 4.17
loading
Precedente Chiudi:
$4.28
Aprire:
$4.29
Volume 24 ore:
573.29K
Relative Volume:
0.82
Capitalizzazione di mercato:
$534.17M
Reddito:
$193.01M
Utile/perdita netta:
$-12.15M
Rapporto P/E:
-46.33
EPS:
-0.09
Flusso di cassa netto:
$454.00K
1 W Prestazione:
-6.71%
1M Prestazione:
-19.81%
6M Prestazione:
-12.03%
1 anno Prestazione:
-39.21%
Intervallo 1D:
Value
$4.16
$4.29
Intervallo di 1 settimana:
Value
$4.16
$4.61
Portata 52W:
Value
$4.16
$7.63

Cytek Biosciences Inc Stock (CTKB) Company Profile

Name
Nome
Cytek Biosciences Inc
Name
Telefono
(877) 922-9835
Name
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Name
Dipendente
648
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
CTKB's Discussions on Twitter

Confronta CTKB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
CTKB
Cytek Biosciences Inc
4.17 534.17M 193.01M -12.15M 454.00K -0.09
Medical Devices icon
ABT
Abbott Laboratories
130.28 225.95B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
96.42 142.29B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
363.84 138.83B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
91.51 117.34B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
68.51 40.28B 5.72B 4.17B 259.90M 6.97

Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-01-31 Downgrade Goldman Buy → Sell
2023-12-14 Iniziato Stephens Overweight
2023-07-19 Iniziato Raymond James Mkt Perform
2022-01-06 Ripresa Piper Sandler Overweight

Cytek Biosciences Inc Borsa (CTKB) Ultime notizie

pulisher
Mar 12, 2025

Cytek Biosciences stock hits 52-week low at $4.19 amid market challenges - Investing.com India

Mar 12, 2025
pulisher
Mar 08, 2025

Cytek Biosciences, Inc. (CTKB): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? - Insider Monkey

Mar 08, 2025
pulisher
Mar 06, 2025

12 Cash-Rich Penny Stocks To Buy According To Hedge Funds - Insider Monkey

Mar 06, 2025
pulisher
Mar 05, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2024 Earnings Call Transcript - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

Cytek Biosciences (CTKB) Expected to Announce Quarterly Earnings on Wednesday - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by Principal Financial Group Inc. - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Cytek Biosciences (NASDAQ:CTKB) Price Target Cut to $8.00 by Analysts at Piper Sandler - Defense World

Mar 05, 2025
pulisher
Mar 03, 2025

Cytek Biosciences Reports Mixed Earnings Amid Growth and Challenges - TipRanks

Mar 03, 2025
pulisher
Mar 02, 2025

Cytek Biosciences (NASDAQ:CTKB) Hits New 1-Year Low – Here’s Why - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Cytek Biosciences stock hits 52-week low at $4.6 amid market challenges - Investing.com Australia

Mar 01, 2025
pulisher
Mar 01, 2025

Is There An Opportunity With Cytek Biosciences, Inc.'s (NASDAQ:CTKB) 22% Undervaluation? - Yahoo Finance

Mar 01, 2025
pulisher
Feb 28, 2025

Cytek Biosciences (NASDAQ:CTKB) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Cytek Biosciences stock hits 52-week low at $4.6 amid market challenges By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 28, 2025

Cytek Biosciences, Inc. SEC 10-K Report - TradingView

Feb 28, 2025
pulisher
Feb 28, 2025

Cytek Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 28, 2025
pulisher
Feb 27, 2025

Cytek Biosciences Reports Growth and Strategic Expansion - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Cytek Biosciences earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Cytek Biosciences Q4 2024 results miss forecasts By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

Cytek Biosciences, Inc. (CTKB) Tops Q4 Earnings Estimates - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Cytek Biosciences Q4 2024 results miss forecasts - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Cytek Biosciences reports Q4 revenue $57.48M, consensus $59.38M - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook - GlobeNewswire

Feb 27, 2025
pulisher
Feb 27, 2025

Cytek's Earnings Show Profitability Surge: Net Loss Halved While Revenue Climbs Just 4% - StockTitan

Feb 27, 2025
pulisher
Feb 24, 2025

Cytek Biosciences (CTKB) to Release Quarterly Earnings on Thursday - MarketBeat

Feb 24, 2025
pulisher
Feb 23, 2025

(CTKB) Proactive Strategies - Stock Traders Daily

Feb 23, 2025
pulisher
Feb 21, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Short Interest Update - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

Cytek Biosciences (CTKB) Projected to Post Quarterly Earnings on Thursday - Defense World

Feb 21, 2025
pulisher
Feb 15, 2025

Cytek Biosciences (NASDAQ:CTKB) Sees Strong Trading VolumeHere's What Happened - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

Prenetics Global (NASDAQ:PRE) and Cytek Biosciences (NASDAQ:CTKB) Head to Head Analysis - Defense World

Feb 14, 2025
pulisher
Feb 13, 2025

Cytek Biosciences to Announce Q4 and Full Year 2024 Financial Results on February 27, 2025 - Nasdaq

Feb 13, 2025
pulisher
Feb 13, 2025

Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - GlobeNewswire

Feb 13, 2025
pulisher
Feb 13, 2025

Cytek Biosciences Earnings Alert: Key Q4 and Full Year 2024 Results Coming February 27 - StockTitan

Feb 13, 2025
pulisher
Feb 13, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Stock's 28% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St

Feb 13, 2025
pulisher
Feb 11, 2025

Cytek Biosciences (NASDAQ:CTKB) Sees Unusually-High Trading Volume – Here’s What Happened - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Keeping an Eye on Cytek BioSciences Inc (CTKB) After Insider Trading Activity - Knox Daily

Feb 10, 2025
pulisher
Feb 08, 2025

Cytek Biosciences (NASDAQ:CTKB) Trading Down 4%Should You Sell? - MarketBeat

Feb 08, 2025
pulisher
Feb 07, 2025

Cytek Biosciences (NASDAQ:CTKB) Shares Up 5%What's Next? - MarketBeat

Feb 07, 2025
pulisher
Feb 05, 2025

Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire

Feb 05, 2025
pulisher
Feb 05, 2025

Strategic Investor Access: Cytek Sets Ambitious 4-Conference Roadshow for Early 2025 - StockTitan

Feb 05, 2025
pulisher
Feb 05, 2025

Pacer Advisors Inc. Buys Shares of 30,155 Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

Cytek Biosciences (NASDAQ:CTKB) Trading Down 4% – Should You Sell? - Armenian Reporter

Feb 04, 2025
pulisher
Feb 04, 2025

Market Insights: Cytek BioSciences Inc (CTKB)’s Notable Gain of 4.66, Closing at 5.39 - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Cytek Biosciences (NASDAQ:CTKB) Shares Gap DownHere's Why - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

Cytek Biosciences price target raised to $5.25 from $4.50 at Goldman Sachs - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

Cytek Biosciences (NASDAQ:CTKB) Cut to Sell at The Goldman Sachs Group - Defense World

Feb 03, 2025

Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_devices ZBH
$104.03
price down icon 3.08%
medical_devices STE
$224.45
price down icon 1.58%
medical_devices PHG
$26.65
price down icon 0.34%
$70.76
price up icon 0.71%
$83.79
price down icon 2.10%
medical_devices EW
$68.51
price up icon 0.18%
Capitalizzazione:     |  Volume (24 ore):